Doctor profile · Federal record
Dr. Rachel Wheatley, M.D.
Dermatology Physician (CMS: Dermatology) · Seattle, WA
- NPI 1518493014
- Accepts Medicare
- 9 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1448 Nw Market St
Seattle, WA 981073743
(206) 329-1760 - Mailing address
-
Po Box 5127
Everett, WA 982065127
Credentials & registration
- NPI registered
- May 2017 — 9 yrs on file
- Profile last updated
- December 24, 2025
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Washington #MD61232200
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1518493014. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,046
Distinct HCPCS
10
Medicare allowed
$76,048
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 389 | 84 | $8 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 181 | 148 | $140 | |
17000 |
Destruction of precancer skin growth, 1 growth | 141 | 114 | $60 | |
11102 |
Biopsy of related skin growth, first growth | 88 | 79 | $111 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 57 | 46 | $63 | |
17110 |
Destruction of skin growth, 1-14 growths | 51 | 40 | $131 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 47 | 39 | $99 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 39 | 39 | $182 | |
11103 |
Biopsy of related skin growth, each additional growth | 30 | 20 | $58 | |
12032 |
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 12 | 12 | $345 |
In context: peer comparison
Among 35 peers in this city , average services per provider: 127. This provider delivers 8.2× the peer median.Open Payments
Industry payments received
All-time total
$3,676
Transactions
179
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| PFIZER INC. | 19 | $418.29 | |
| Incyte Corporation | 13 | $352.71 | |
| GENZYME CORPORATION | 12 | $335.39 | |
| ABBVIE INC. | 12 | $296.49 | |
| Regeneron Healthcare Solutions, Inc. | 14 | $288.93 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $270.22 | |
| Arcutis Biotherapeutics, Inc. | 16 | $260.48 | |
| Novartis Pharmaceuticals Corporation | 24 | $247.78 | |
| UCB, Inc. | 6 | $239.64 | |
| E.R. Squibb & Sons, L.L.C. | 16 | $232.09 | |
| Janssen Biotech, Inc. | 9 | $185.82 | |
| Dermavant Sciences, Inc. | 10 | $172.80 | |
| Lilly USA, LLC | 8 | $165.74 | |
| Galderma Laboratories, L.P. | 6 | $112.90 | |
| LEO Pharma Inc. | 3 | $71.31 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
181
Patients
147
Total drug cost
$5,492
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 64 | 50 | $606 |
| Clobetasol Propionate | Generic | 28 | 22 | $2,233 |
| Mupirocin | Generic | 24 | 19 | $217 |
| Hydrocortisone | Generic | 21 | 18 | $168 |
| Fluocinolone Acetonide | Generic | 16 | 14 | $1,197 |
| Ketoconazole | Generic | 16 | 13 | $363 |
| Fluorouracil | Generic | 12 | 11 | $710 |
Frequently asked questions
What is Dr. Rachel Wheatley's medical specialty?
Dr. Rachel Wheatley practices Dermatology Physician in Seattle, WA.
Where does Dr. Rachel Wheatley practice?
Dr. Rachel Wheatley practices at 1448 Nw Market St, Seattle, WA 981073743. Office phone: 2063291760.
What is Dr. Rachel Wheatley's NPI?
Dr. Rachel Wheatley's National Provider Identifier (NPI) is 1518493014, issued by NPPES.
Does Dr. Rachel Wheatley accept Medicare assignment?
Yes. Dr. Rachel Wheatley accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rachel Wheatley commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99214); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.